Why Closing Lung Cancer’s Diagnostic Gap Will Require New Lab Strategies
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read MorePosted by Alyx Arnett | Sep 25, 2025 | Lung Cancer |
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read MorePosted by CLP Edit Staff | Sep 25, 2025 | Middleware & Software |
The collaboration will provide automated narrative summaries and biomarker insights to reduce interpretation workload across laboratory disciplines.
Read MorePosted by CLP Edit Staff | Sep 24, 2025 | Molecular Diagnostic Analyzers |
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read MorePosted by CLP Edit Staff | Sep 24, 2025 | Company News |
The proteomics company will use capital to advance partner-driven product development and commercial operations from new California headquarters.
Read MorePosted by CLP Edit Staff | Sep 24, 2025 | Molecular Diagnostic Analyzers |
The collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.
Read More